Whole Body Vibration in Middle Aged Men
Launched by JOUF UNIVERSITY · Oct 14, 2024
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of Whole Body Vibration (WBV) on bone health and muscle strength in middle-aged men. The researchers want to see if an 8-week program of WBV can improve bone mineral density (which helps prevent fractures), hand grip strength, and vitamin D levels, compared to a placebo (a treatment that has no active effect). This study could help determine if WBV is a good alternative for those who may have trouble with regular exercise.
To participate in the trial, men aged 50 and older are welcome, as long as they are generally healthy and not involved in other clinical studies. Participants should not have serious medical conditions like heart disease or a history of fractures, and they must be non-smokers. Those who join will stand on a platform that uses vibrations for the sessions, which are designed to be safe and accessible. This trial is currently not recruiting participants, but it is an important step in exploring new ways to support bone and muscle health in middle-aged men.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male participants aged 50 years or older
- • Participants with physical activity or exercise program involvement
- • Participants with no history of serious medical conditions such as tumors, fractures, epilepsy, cardiac disease, or stroke within the past year.
- • Participants must be non-smokers and not receiving hormone or calcium supplement therapy
- Exclusion Criteria:
- • Participants unable to stand on the WBV platform
- • Participants with conditions contraindicating vibration therapy
- • Participants participating in other clinical trials
About Jouf University
Jouf University is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. Committed to excellence in education and community service, the university fosters a collaborative environment that bridges scientific inquiry with practical applications. With a focus on addressing pressing health challenges, Jouf University leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical trials that contribute to the development of new therapies and improve patient outcomes. Through its dedication to ethical standards and patient safety, Jouf University aims to enhance the quality of healthcare delivery and promote evidence-based practices in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sakaka, Aljouf, Saudi Arabia
Patients applied
Trial Officials
Fahad Alanazi, PhD
Principal Investigator
Jouf University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported